Advertisement
Australia markets closed
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • AUD/USD

    0.6519
    -0.0017 (-0.26%)
     
  • OIL

    83.11
    +1.76 (+2.16%)
     
  • GOLD

    2,254.80
    +42.10 (+1.90%)
     
  • Bitcoin AUD

    108,776.11
    +2,599.69 (+2.45%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6036
    +0.0005 (+0.09%)
     
  • AUD/NZD

    1.0910
    +0.0030 (+0.27%)
     
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NASDAQ

    18,254.69
    -26.15 (-0.14%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,807.37
    +47.29 (+0.12%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     

Top Stock Reports for NIKE, Cisco Systems & Gilead Sciences

BOJA vs. SBUX: Which Stock Is the Better Value Option?

Friday, October 13, 2017

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NIKE (NKE), Cisco Systems (CSCO) and Gilead Sciences (GILD). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

NIKE has lagged the Zacks Shoes and Retail Apparel industry in the past three months (-12.4% vs. -10.7%), due to lackluster sales in its key North American market. Notably, sales in the region dipped 3% in first-quarter fiscal 2018, wherein the gross margin was hurt by currency woes and a higher mix of off-price sales. The company anticipates near-term results to be hurt by the tough retail environment, which led to a bleak second quarter view.

ADVERTISEMENT

However, the company’s robust growth and innovation efforts have been reflected in every quarter’s results for over three fiscal years now. The company’s last reported quarter gained from strength in international business and the global NIKE Direct business.

Also, NIKE has been focused on its Consumer Direct Offense plan. Driven by its Triple Double strategy, this restructuring plan focuses on using digital methods for rapid innovation and product development, along with strengthening consumer relations by operating through core regions.

(You can read the full research report on NIKE here >>>).

Cisco has outperformed the Zacks Computer Networking industry on a year-to-date basis, gaining +10.1% vs. a rise of +9.5%. The company’s expanding footprint in the rapidly growing security market presents significant growth opportunity. Further, the company’s focus on driving cost improvement, operational efficiencies and productivity will help in margin expansion. Additionally, partnerships with Telenor, Apple, IBM and Microsoft are positive in our view. Moreover, the recently updated ACI solution will boost expertise in the SDN market.

However, top-line will continue suffer from intensifying competition, slowing order growth from service providers and challenges in the emerging markets. The Zacks analyst continues to believe that the time-consuming transition to subscription-based business model will hurt top line growth at least in the near term. Estimates have been stable lately ahead of the company's Q1 earnings release. The company has mixed record of earnings surprises in recent quarters.

(You can read the full research report on Cisco here >>>).

Shares of Gilead have outperformed the Zacks Biotech industry so far in 2017, increasing +13.5% vs. a gain of +13%.The company acquired Kite Pharma to foray into the CAR T therapy space which represents immense potential at this juncture and a potential approval of lead candidate axi-cell (expected in November) will be a significant boost for Gilead’s prospects which has dampened of late.

Gilead had a strong cash balance and the decline in the once lucrative hepatitis C (HCV) market due to competitive pressure made the company look for strategic alternatives. The Zacks analyst notes that Gilead is known for its presence in the HCV market because of its blockbuster HCV drugs, Sovaldi and Harvoni.

However, the HCV franchise is under pressure because of competition and pricing issues. Meanwhile, the HIV franchise maintains momentum driven by the rapid adoption of TAF-based regimens in the U.S. and EU.

(You can read the full research report on Gilead Sciences here >>>).

Other noteworthy reports we are featuring today include Las Vegas Sands (LVS), Dominion Energy (D) and Aon (AON).

4 Stocks to Watch after the Massive Equifax Hack

Cybersecurity stocks spiked on recent news of a data breach affecting 143 million Americans. But which stocks are the best buy candidates right now? And what does the future hold for the cybersecurity industry?

Equifax is just the most recent victim. Computer hacking and identity theft are more common than ever. Zacks has just released Cybersecurity! An Investor’s Guide to inform Zacks.com readers about this $170 billion/year space. More importantly, it highlights 4 cybersecurity picks with strong profit potential.

Get the new Investing Guide now>>

Mark Vickery

Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Today's Must Read

Consumer Direct Offense Plan to Aid Growth at Nike (NKE)

Cisco (CSCO) Drives on Partnerships, Enhanced ACI Solution

Gilead (GILD) Acquires Kite to Diversify As HCV Remains Weak

Featured Reports

Mining Cost Cuts, Exploration Projects Aid Goldcorp (GG)

Per the Zacks analyst, Goldcorp's focus on lower mining costs will boost its margins. The company should also gain from its key exploration projects.

Time Warner's (TWX) Digital Endeavors to Enhance Revenue

Per the Zacks analyst, Time Warner's investments in video content and digital efforts bode well. However, expected fall in advertising revenue at Turner segment in the third quarter remains a concern.

ServiceNow (NOW) Banks on SAP Integration, New HR Solution

Per the Zacks analyst, ServiceNow is expected to benefit from the product integration with SAP SuccessFactor.

Aon's (AON) Strong Cash Position Impresses, Debt Level Hurts

Per the Zacks analyst, although Aon's solid cash position pave the way for growth oriented strategies like mergers and acquisitions, its rising level of debt continues to weigh on the margins.

Global Network Aids Henry Schein (HSIC), Margin Woes to Stay

Per the Zacks analyst, Henry Schein gains from extensive global foothold and diverse channel mix. Yet the DENTSPLY SIRONA deal may intensify its weak operating margin.

Drop in Solar investment tax credit will hurt Dominion (D)

The Zacks analyst believes drop in solar investment tax credit will hurt Dominion despite the fact that the company registered gain from acquisition and systematic investments.

Rise in Rates Aid Edison International (EIX), Penalties Ail

Per the Zacks analyst, a sharp rise in its regulated rate base has been boosting Edison International's growth. Yet penalties arising out of investigations in its operations may hurt the stock.

New Upgrades

Easing Margin Pressure, GEAM Deal Support State Street (STT)

Per the Zacks analyst, easing margin pressure, synergies from GE Asset Management (GEAM) deal and new business wins should support State Street's profitability in the quarters ahead.

Las Vegas Sands (LVS) Rides on Diversification, New Resort

Per the Zacks analyst, The Parisian Macao will continue to attract tourists and leisure gamblers, thereby boosting revenues. Efforts to diversify its revenue sources is also likely to drive growth.

Omnicom (OMC) Enhances Digital Capabilities to Boost Revenue

Per the Zacks analyst, Omnicom is building upon its digital and analytical capabilities by investing in agencies and partnering with innovative technology firms in key markets to boost revenues.

New Downgrades

Drop in U.K. Regulated Earnings to Impact PPL Corp. (PPL)

Per the Zacks analyst a likely drop in U.K. regulated earnings will hurt PPL Corp., despite its investments to strengthen infrastructure, transmission and distribution systems.

Sirius XM (SIRI) Hurt by High Operating Expenses

The Zacks analyst is worried about the company's high operating expenses. This is likely to limit bottom-line growth in the third quarter. The company's high debt levels also raise concerns.

Falling Value of Proved Reserves Hurts Range Resources (RRC)

The Zacks analyst is concerned about Range Resources' declining value of estimated proved reserves following low natural gas price. This might lead the company's lender to lower the borrowing base.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Nike, Inc. (NKE) : Free Stock Analysis Report
 
Las Vegas Sands Corp. (LVS) : Free Stock Analysis Report
 
Gilead Sciences, Inc. (GILD) : Free Stock Analysis Report
 
Dominion Energy Inc. (D) : Free Stock Analysis Report
 
Cisco Systems, Inc. (CSCO) : Free Stock Analysis Report
 
Aon PLC (AON) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research